Bayer has appointed Dr Carsten Brunn as the president of its pharmaceuticals business in the Americas, overseeing the company’s operations in the US, Canada and Central and Latin America.
Dr Brunn first joined Bayer in 2011 as global head of primary care, based in Beijing, China, and has subsequently served as head of Bayer’s pharmaceuticals commercial operations in Japan since 2013.
Prior to this, Dr Brunn was vice president of pharma, Asia-Pacific at Bausch & Lomb and served as global head of marketing at Basilea Pharmaceutica International, based in Basel, Switzerland.
He also brings branding and sales leadership experience from Novartis and Eli Lilly, and recently served as chairman of European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan.
Dieter Weinand, president of Bayer’s pharmaceutical division, said: “Carsten is a strategic and highly respected leader in the pharmaceutical industry and I’m delighted to have him lead the company’s largest pharmaceutical business worldwide.
“Carsten’s global perspective and proven track record of successful operational executive at the local level will be a critical asset to us as we continue to build on our current momentum in the US and across the Americas region.”